Chemo/Immunotherapy Data Increasingly Compelling with Additional Follow-Up (BMIC-009)
from The Beacon (Audio) Hosted by H. Jack West, MD
Dr. Jack West assesses the merits of a combination of chemotherapy with pembrolizumab (Keytruda) based on the evolving efficacy data, especially the maturing results for overall survival, with longer follow-up of the KEYNOTE-021g trial.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The Beacon (Audio)?
This episode is 7 minutes long.
When was this The Beacon (Audio) episode published?
This episode was published on September 25, 2017.
Can I download this The Beacon (Audio) episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.